Bristol-Myers Squibb, which sells blood thinner Plavix, today reported better-than-expected third quarter earnings, mainly due to cost cuts. Revenue, however, fell short of expectations, and shares are down in trading Tuesday.
Continue reading Bristol-Myers Squibb Earnings Top Estimates, Revenue Disappoints
Bristol-Myers Squibb Earnings Top Estimates, Revenue Disappoints originally appeared on DailyFinance on Tue, 26 Oct 2010 11:35:00.
Filed Under: Company News, Health Care, Earnings, Bristol-Myers Squibb, Stocks in the News